LASIK & PRK: still looks good ten years on

Article

LASIK for myopia over -10 D is a safe procedure; myopic regression slows down with time and there is a high rate of best spectacle corrected visual acuity (BSCVA) increase in the long-term.

LASIK for myopia over -10 D is a safe procedure; myopic regression slows down with time and there is a high rate of best spectacle corrected visual acuity (BSCVA) increase in the long-term, according to Jorge Alio, MD and colleagues from the VISSUM Instituto Oftalmológico de Alicante and the Miguel Hernandez University Medical School, Spain.

A total of 196 myopic eyes (118 patients) with a mean preoperative spherical equivalent (SE) of -13.95±2.79 D were included in the study. Myopic LASIK was performed using the VISX 20/20 excimer laser (AMO) with a 6 mm ablation zone. Patients were evaluated at three months, one, two, five and 10 years.

At 10 years follow-up, 82 eyes (42%) were within ±1.00 D and 54 eyes (27.5%) had undergone re-treatments. The mean SE decreased, in eyes that did not receive re-treatments, with a mean rate of -0.25±0.18 D per year that slowed over time. Overall, 124 eyes (63%) demonstrated an increase in BSCVA after 10 years follow-up. Two eyes (1%), with more than 15 D myopic correction, developed corneal ectasia.

…and so does PRK

The same research team also claimed that photorefractive keratectomy (PRK) for myopia over -10 D is a safe procedure with a high rate of BSCVA increase in the long term.

In a further study, 70 eyes (50 patients) with myopia ranging between -10.00 and -17.75 D underwent myopic PRK with the VISX 20/20 excimer laser (AMO) with a 6 mm ablation zone and were followed-up for a ten-year period.

Twenty-eight eyes (40%) were within ±1.00 D at 10 years follow-up and 28 eyes (40%) underwent re-treatments. Mean SE decreased over 10 years at a rate of 0.23±0.30 D per year that slowed down with time. Forty-one eyes (58%) demonstrated an increase in BSCVA after 10 years and only five (7.1%) lost more than two lines of BSCVA. The mean corneal haze score decreased gradually from 0.87±0.83 at three months to 0.16±0.45 at 10 years.

The authors of these two studies suggest that both LASIK and PRK are safe and effective procedures for the correction of high myopia.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.